NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026)
NeuroPace (NPCE) posted quarterly Cash from Investing Activities of -$117000.0 for Q1 2026, down 216.22% year-over-year from $100674.4 in Q1 2025, and down 20.62% quarter-over-quarter from -$97000.0 in Q4 2025.
NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026) Analysis & Trends
NeuroPace's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$117000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 216.22% year-over-year to -$117000.0; the TTM figure through Mar 2026 stood at -$412000.0 (down 106.28% YoY), while the FY2025 annual figure was -$332000.0, down 103.69% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$117000.0, down from -$97000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $10.1 million in Q1 2023, with the low at -$306000.0 in Q1 2022.
- The 5-year median for Cash from Investing Activities is $2.4 million (2024), against an average of $3.3 million.
- The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities jumped 5877.92% in 2022, then tumbled 216.22% in 2026.
- NeuroPace's Cash from Investing Activities stood at $8.9 million in 2022, then plunged by 61.02% to $3.5 million in 2023, then plunged by 43.45% to $2.0 million in 2024, then sank by 104.95% to -$97000.0 in 2025, then fell by 20.62% to -$117000.0 in 2026.
- Business Quant data shows NPCE's Cash from Investing Activities at -$117000.0 in Q1 2026, -$97000.0 in Q4 2025, and -$30000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | -125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -125,000.00 |
| Jun 30, 2026 | -125,000.00 |
| Mar 31, 2026 | -117,000.00 |
| Mar 31, 2026 | -117,000.00 |
| Dec 31, 2025 | -97,000.00 |
| Dec 31, 2025 | -97,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Jun 30, 2025 | -168,000.00 |
| Jun 30, 2025 | -168,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Dec 31, 2024 | 1.96 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.40 Mn |